References
1. Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med. 2008;120:34–41.
2. Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2004;110:2952–2967.
3. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–1932.
4. Artham S, Lavie C, Milani R, Ventura H. Obesity and Hypertension, Heart Failure, and Coronary Heart Disease— Risk Factor, Paradox, and Recommendations for Weight Loss The Ochsner Journal 2009 9:124–132.
5. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–313.
6. Jousilahti P, Tuomilehto J, Vartiainen E, et al. Body weight, cardiovascular risk factors, and coronary mortality: 15-year followup of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372–1379.
7. Miller MT, Lavie CJ, White CJ. Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr. 2008;3:162–167.
8. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–977.
9. McGill HC Jr, McMahan CA, Herderick EE. et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712–2718.
10. Rahmouni K, Correia ML, Haynes WG, et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2004;45:9–14.
11. Festa A, D’Agostine R Jr, Williams K, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25:1407–1415.
12. Traupe T, Lang M, Goettsch W, et al. Obesity increases prostanoid mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens. 2002;20:2239–2245.
13. Ornish D et al. Can lifestyle changes reverse heart disease? The lifestyle heart trial. Lancet 1990; 336;129-133.
14. Schmidt T, Wijga A, Von Zur Muhlen A, Brabant G, Wagner TO. Changes in cardiovascular risk factors and hormones during a comprehensive residential three month kriya yoga training and vegetarian nutrition. Acta Physiol Scand Suppl 1997;640:158–62.
15. Mahajan AS, Reddy KS, Sachdeva U. Lipid profile of coronary risk subjects following yogic lifestyle intervention. Indian Heart J 1999;51:37–40.
16. Manchanda SC, Narang R, Reddy KS, Sachdeva U, Prabhakaran D, Dharmanand S, et al. Retardation of coronary atheroscl-erosis with yoga lifestyle intervention. J Assoc Physicians India 2000;48:687–94.
17. Yogendra J, Yogendra HJ, Ambardekar S, Lele RD, Shetty S, Dave M, et al. Beneficial effects of yoga lifestyle on reversibility of ischaemic heart disease: caring heart project of International Board of Yoga. J Assoc Physicians India 2004;52:283–9.
18. Oreopaulos A, Padural R, Norris CM et al. Effect of obesity on short and long term mortality post coronary revascularisation: a meta analysis. Obesity 2008, 16:442-450.
19. Lavie CJ, Milani RV, Artham SM. Combating the obesity paradox— benefits and safety of purposeful weight loss in overweight and obese coronary patients. J Am Coll Cardiol. 2008;5(10 suppl A):A107.
20. Lavie CJ, Morshedi-Meibodi A, Milani RV. Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients. J Cardiometab Syndr. 2008;3: 136–140.
DOI: https://dx.doi.org/10.18535/jmscr/v5i1.66
